MedPath

BRIDION

These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION (sugammadex) Injection, for intravenous use Initial U.S. Approval: 2015

Approved
Approval ID

9e3eb206-5c35-2c93-e053-2a95a90a9df0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 10, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sugammadex

PRODUCT DETAILS

NDC Product Code71872-7187
Application NumberNDA022225
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateMay 10, 2023
Generic Namesugammadex

INGREDIENTS (4)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SUGAMMADEX SODIUMActive
Quantity: 100 mg in 1 mL
Code: ERJ6X2MXV7
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
BRIDION - FDA Approval | MedPath